Patents by Inventor Fiona McDonald

Fiona McDonald has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110172222
    Abstract: The present invention relates to the use of selective inhibitors of coagulation factor Xa, in particular of oxazolidinones of the formula (I), for the treatment and/or prophylaxis of inflammatory conditions of the gastrointestinal tract such as inflammatory bowel disease (IBD) and celiac disease and/or disorders related to inflammatory bowel disease (IBD) and/or celiac disease such as thromboembolic events (including e.g. pulmonary embolism (PE), arterial and venous thrombosis, myocardial infarction, stroke) as well their use for the preparation of pharmaceutical drugs for the treatment and/or prophylaxis of inflammatory bowel disease (IBD) and/or celiac disease and/or disorders related to inflammatory bowel disease (IBD) and/or celiac disease such as thromboembolic events.
    Type: Application
    Filed: June 23, 2009
    Publication date: July 14, 2011
    Applicant: Bayer Schering Pharma Aktiengesellschaft
    Inventors: Georges Von Degenfeld, Elisabeth Perzborn, Wolfgang Thielemann, Susanne Röhrig, Fiona McDonald
  • Publication number: 20070049583
    Abstract: Compounds of formula (I), their tautomeric and isomeric forms and salts, as well as the process for their production and their use in pharmaceutical compositions, are described.
    Type: Application
    Filed: October 25, 2006
    Publication date: March 1, 2007
    Applicant: Schering Aktiengesellschaft
    Inventors: Peter Holscher, Hartmut Rehwinkel, Stefan Jaroch, Detlev Sulzle, Margrit Hillmann, Gerardine Burton, Fiona McDonald
  • Patent number: 6914059
    Abstract: Compounds of formula I, their tautomeric and isomeric forms and salts, as well as the process for their production and their use in pharmaceutical agents are described.
    Type: Grant
    Filed: April 12, 2001
    Date of Patent: July 5, 2005
    Assignee: Schering AG
    Inventors: Hartmut Rehwinkel, Peter Hoelscher, Stefan Jaroch, Detlev Suelzle, Margrit Hillmann, Gerardine Anne Burton, Fiona Mcdonald McDonald
  • Publication number: 20050119481
    Abstract: Amidine derivatives of formula I, their tautomeric and isomeric forms and salts as well as the process for their production and their use for the production of a pharmaceutical agent are described.
    Type: Application
    Filed: December 10, 2002
    Publication date: June 2, 2005
    Inventors: Hartmut Rehwinkel, Peter Hoelscher, Stefan Jaroch, Detlev Suelzle, Margrit Hillmann, Gerardine Burton, Fiona McDonald
  • Publication number: 20030191110
    Abstract: The present invention relates to methods for modulating the cholesterol biosynthetic pathway. The level of cholesterol in the body is linked to numerous pathological states. The methods of the present invention alter the transcription levels of genes involved in the cholesterol biosynthesis. The methods of the present invention can used for treating diseases mediated by the cholesterol biosynthetic pathway.
    Type: Application
    Filed: November 1, 2002
    Publication date: October 9, 2003
    Inventors: Martyn Botfield, Fiona McDonald, Joern Kraetzschmar, Bernhard Lindenthal, Bertold Kreft
  • Patent number: 6284779
    Abstract: The invention relates to the compounds of Formula I as well as the process for their production and their use as pharmaceutical agents.
    Type: Grant
    Filed: February 1, 2000
    Date of Patent: September 4, 2001
    Assignees: Schering Aktiiengesellschaft, Vertex Pharmaceuticals Incorporated
    Inventors: Thomas Brumby, Fiona McDonald, Eckhard Ottow, Herbert Schneider